 Hello, everyone. I'm Isana, my background is medical doctor from Indonesia, and I'm part of Okra Indonesia, based in Oxford. And now I'm second-year degree of students, and my project will about investigating the role of gamma delta T cell in the susceptibility to infection, and this is outcome in individual with type 2 diabetes. So the number of diabetes is increasing, and based on international diabetes federation, the number will increase until 46% in the next 2 decades. And most of the case will happen in the limited settings. And in that area, the number of infectious diseases is high prevalence, such as tuberculosis and maloidosis. And also during the pandemic, diabetes is one of the risk factor to get the seat of your COVID-19 and bring to infection. And previous findings also show that no trophial to delta 2 lymphosectomysio is a better prognosis marker To predict severity of COVID-19, compared to the conventional use of the trophial to CD80 cellular ratio. That's why I'm interested to explore more the role of gamma delta T cells in the diabetes maletus. So what is gamma delta T cell? This is the unconventional T cell that can access the bridging immunity between innate to adaptive. So in it is when the immune response acts in the early time, which is nonspecific and then later it developed to the adaptive immunity, which is protect in the longer time. And gamma delta T cell can bridging by orchestrating the immune response from the beginnings of infection by producing pro-inflammatory cytokines. And then it's helping to create the memory cell which we can provide longer protection. And usually it could be recalled by vaccinations. And in the blood, the majority of the subset of gamma delta T cell is gamma 9 and delta 2. That's why I will focus more to exploring this subset of cells. Dan in the first year of dental, I try to investigate the function of gamma delta T cell in DM compared to non-DM patient. And then in the next time, I plan to investigate the function in acute maloidosis and acute COVID-19 patient with and without DM. And then I try to investigate the crosstalk between the cell and the other immune cell. And also it's correlation with the disease security and disease outcome. And hopefully my research could help in the developing vaccination strategy in vulnerable populations such as the eubatis malatus.